2m 2m 2m 2m 2m 2m 2m
- $517,373.00Market Cap
- -99.92%1-Year Change
- Medical Care FacilitiesIndustry
NEWGENIVF-A (NIVF)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 51
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
NewGen Reports Total Gain from IP Acquisition of $17.9 Million for FY 2025
NewGenIvf Group acquired advanced cytometry intellectual property, receiving a valuation of $17.9 million, which boosts the company's net asset value and marks a strategic transition from traditional IVF services to a technology-driven service provider.
10/06/2025, 8:30 AM • Benzinga
NewGenDigital, a subsidiary of NewGenIvf Group, has secured a strategic 110,400 sq. ft. plot in Ras Al Khaimah, UAE, and is exploring real world asset tokenization using blockchain technology, with potential sales revenue exceeding $400 million.
07/01/2025, 7:00 AM • Benzinga
Peers
Statistics
MoreInformation as of 06/03/2026
Company Profile
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
Key Executives
- Hei Yue Fong
- Wing Fung Siu
- Fai Chung
Current Ownership Distribution
- Insiders1.7M (87.78%)
- Mutual Funds240,100 (12.13%)
- Institutions1,706 (0.09%)
- Other0 (0.00%)